ynngy
2021-04-13
nooo
Why Canopy Growth, Aurora Cannabis, and Hexo Stocks Went Up in Smoke Monday<blockquote>为什么 Canopy Growth、Aurora Cannabis 和 Hexo 股票周一大幅上涨</blockquote>
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
4
2
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":345358733,"tweetId":"345358733","gmtCreate":1618281253222,"gmtModify":1634293968582,"author":{"id":3575273190676019,"idStr":"3575273190676019","authorId":3575273190676019,"authorIdStr":"3575273190676019","name":"ynngy","avatar":"https://static.tigerbbs.com/c3b764c34a3be814280b5ed823bbb9c7","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":11,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body><p>nooo</p></body></html>","htmlText":"<html><head></head><body><p>nooo</p></body></html>","text":"nooo","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":4,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/345358733","repostId":1151812879,"repostType":4,"repost":{"id":"1151812879","kind":"news","pubTimestamp":1618279758,"share":"https://www.laohunote.com/m/news/1151812879?lang=zh_CN&edition=full","pubTime":"2021-04-13 10:09","market":"us","language":"en","title":"Why Canopy Growth, Aurora Cannabis, and Hexo Stocks Went Up in Smoke Monday<blockquote>为什么 Canopy Growth、Aurora Cannabis 和 Hexo 股票周一大幅上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1151812879","media":"Motley Fool","summary":"Blame Aphria.\nWhat happened\nIt's Monday, and marijuana stocks are vaporizing.Canopy Growth (NASDAQ:C","content":"<p>Blame Aphria.</p><p><blockquote>怪阿弗里亚。</blockquote></p><p> <b>What happened</b></p><p><blockquote><b>发生了什么事</b></blockquote></p><p> It's Monday, and marijuana stocks are vaporizing.<b>Canopy Growth</b> (NASDAQ:CGC) stock is down a depressing 4.7%, and cannabis rivals <b>Aurora Cannabis</b> (NYSE:ACB) and <b>Hexo</b> (NYSE:HEXO) have both tumbled about 9% each.</p><p><blockquote>今天是星期一,大麻库存正在蒸发。<b>冠层生长</b>(纳斯达克股票代码:CGC)股价下跌 4.7%,大麻竞争对手<b>奥罗拉大麻</b>(纽约证券交易所代码:ACB)和<b>六角</b>(纽约证券交易所股票代码:HEXO)均下跌约 9%。</blockquote></p><p> And if you want to know why, ask <b>Aphria</b> (NASDAQ:APHA).</p><p><blockquote>如果你想知道为什么,问<b>阿弗里亚</b>(纳斯达克股票代码:APHA)。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5780413b068fd57f09ff47950d68591b\" tg-width=\"2000\" tg-height=\"1333\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源:盖蒂图片社。</span></p></blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> Yes, unfair as it may feel, the stock to blame for Canopy's, Aurora's, and Hexo's declines today is none of the above, but rather their cannabis-growing rival Aphria, which reported itsfiscal Q3 2021earnings results this morning.</p><p><blockquote>是的,尽管看起来不公平,但今天 Canopy、Aurora 和 Hexo 下跌的原因不是上述任何股票,而是它们种植大麻的竞争对手 Aphria,该公司今天早上公布了 2021 财年第三季度的盈利结果。</blockquote></p><p> Suffice it to say that the news was not good.</p><p><blockquote>可以说这个消息不好。</blockquote></p><p> Sales at the Canadian cannabis company grew a respectable 6% to CA$153.6 million in Q3 2021, but that was well below the CA$166.2 million that analysts had predicted. Worse, Aphria reported a CA$1.14-per-share loss for the quarter, versus the tiny profit (calculated according to generally accepted accounting principles or GAAP) reported a year ago. In terms of U.S. dollars, Aphria lost $0.91 per share.</p><p><blockquote>这家加拿大大麻公司 2021 年第三季度的销售额增长了 6%,达到 1.536 亿加元,但远低于分析师预测的 1.662 亿加元。更糟糕的是,Aphria 报告本季度每股亏损 1.14 加元,而一年前报告的利润微薄(根据公认会计准则 (GAAP) 计算)。以美元计算,Aphria 每股亏损 0.91 美元。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在呢</b></blockquote></p><p> Aphria blamed \"the duration and impact of lockdowns across many of the regions we operate in, particularly in Canada\" for its disappointing results, but insisted that it \"remains well-positioned with our leading brands and market share to experience a robust increase in our top-line as the market improves\" and said it is still \"excited about the strategic opportunities for incremental growth,\" particularly in the U.S. market.</p><p><blockquote>Aphria 将其令人失望的业绩归咎于“我们开展业务的许多地区(尤其是加拿大)封锁的持续时间和影响”,但坚称其“凭借我们的领先品牌和市场份额保持有利地位,随着市场的改善,我们的收入将出现强劲增长”,并表示它仍然“对增量增长的战略机遇感到兴奋”,特别是在美国市场。</blockquote></p><p> Regardless, the fact that Aphria's gross profits on its sales declined by nearly half in the quarter suggests that demand for the product isn't necessarily Aphria's (or Canopy's or Aurora's or Hexo's) biggest problem going forward. Shrinking profit on growing sales speaks to declining pricing power in the industry as oversupply continues to weigh on profitability for medical marijuana and recreational marijuana alike.</p><p><blockquote>无论如何,Aphria 本季度的销售毛利润下降了近一半,这一事实表明,对该产品的需求不一定是 Aphria(或 Canopy、Aurora 或 Hexo)未来最大的问题。随着供应过剩继续影响医用大麻和娱乐用大麻的盈利能力,销售额增长导致利润萎缩,表明该行业定价权下降。</blockquote></p><p> That's not good news for Aphria's future.It's not good news for Canopy Growth, Aurora Cannabis, or Hexo, either.</p><p><blockquote>这对Aphria的未来来说不是好消息。这对 Canopy Growth、Aurora Cannabis 或 Hexo 来说也不是好消息。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Canopy Growth, Aurora Cannabis, and Hexo Stocks Went Up in Smoke Monday<blockquote>为什么 Canopy Growth、Aurora Cannabis 和 Hexo 股票周一大幅上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Canopy Growth, Aurora Cannabis, and Hexo Stocks Went Up in Smoke Monday<blockquote>为什么 Canopy Growth、Aurora Cannabis 和 Hexo 股票周一大幅上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-04-13 10:09</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Blame Aphria.</p><p><blockquote>怪阿弗里亚。</blockquote></p><p> <b>What happened</b></p><p><blockquote><b>发生了什么事</b></blockquote></p><p> It's Monday, and marijuana stocks are vaporizing.<b>Canopy Growth</b> (NASDAQ:CGC) stock is down a depressing 4.7%, and cannabis rivals <b>Aurora Cannabis</b> (NYSE:ACB) and <b>Hexo</b> (NYSE:HEXO) have both tumbled about 9% each.</p><p><blockquote>今天是星期一,大麻库存正在蒸发。<b>冠层生长</b>(纳斯达克股票代码:CGC)股价下跌 4.7%,大麻竞争对手<b>奥罗拉大麻</b>(纽约证券交易所代码:ACB)和<b>六角</b>(纽约证券交易所股票代码:HEXO)均下跌约 9%。</blockquote></p><p> And if you want to know why, ask <b>Aphria</b> (NASDAQ:APHA).</p><p><blockquote>如果你想知道为什么,问<b>阿弗里亚</b>(纳斯达克股票代码:APHA)。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5780413b068fd57f09ff47950d68591b\" tg-width=\"2000\" tg-height=\"1333\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源:盖蒂图片社。</span></p></blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> Yes, unfair as it may feel, the stock to blame for Canopy's, Aurora's, and Hexo's declines today is none of the above, but rather their cannabis-growing rival Aphria, which reported itsfiscal Q3 2021earnings results this morning.</p><p><blockquote>是的,尽管看起来不公平,但今天 Canopy、Aurora 和 Hexo 下跌的原因不是上述任何股票,而是它们种植大麻的竞争对手 Aphria,该公司今天早上公布了 2021 财年第三季度的盈利结果。</blockquote></p><p> Suffice it to say that the news was not good.</p><p><blockquote>可以说这个消息不好。</blockquote></p><p> Sales at the Canadian cannabis company grew a respectable 6% to CA$153.6 million in Q3 2021, but that was well below the CA$166.2 million that analysts had predicted. Worse, Aphria reported a CA$1.14-per-share loss for the quarter, versus the tiny profit (calculated according to generally accepted accounting principles or GAAP) reported a year ago. In terms of U.S. dollars, Aphria lost $0.91 per share.</p><p><blockquote>这家加拿大大麻公司 2021 年第三季度的销售额增长了 6%,达到 1.536 亿加元,但远低于分析师预测的 1.662 亿加元。更糟糕的是,Aphria 报告本季度每股亏损 1.14 加元,而一年前报告的利润微薄(根据公认会计准则 (GAAP) 计算)。以美元计算,Aphria 每股亏损 0.91 美元。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在呢</b></blockquote></p><p> Aphria blamed \"the duration and impact of lockdowns across many of the regions we operate in, particularly in Canada\" for its disappointing results, but insisted that it \"remains well-positioned with our leading brands and market share to experience a robust increase in our top-line as the market improves\" and said it is still \"excited about the strategic opportunities for incremental growth,\" particularly in the U.S. market.</p><p><blockquote>Aphria 将其令人失望的业绩归咎于“我们开展业务的许多地区(尤其是加拿大)封锁的持续时间和影响”,但坚称其“凭借我们的领先品牌和市场份额保持有利地位,随着市场的改善,我们的收入将出现强劲增长”,并表示它仍然“对增量增长的战略机遇感到兴奋”,特别是在美国市场。</blockquote></p><p> Regardless, the fact that Aphria's gross profits on its sales declined by nearly half in the quarter suggests that demand for the product isn't necessarily Aphria's (or Canopy's or Aurora's or Hexo's) biggest problem going forward. Shrinking profit on growing sales speaks to declining pricing power in the industry as oversupply continues to weigh on profitability for medical marijuana and recreational marijuana alike.</p><p><blockquote>无论如何,Aphria 本季度的销售毛利润下降了近一半,这一事实表明,对该产品的需求不一定是 Aphria(或 Canopy、Aurora 或 Hexo)未来最大的问题。随着供应过剩继续影响医用大麻和娱乐用大麻的盈利能力,销售额增长导致利润萎缩,表明该行业定价权下降。</blockquote></p><p> That's not good news for Aphria's future.It's not good news for Canopy Growth, Aurora Cannabis, or Hexo, either.</p><p><blockquote>这对Aphria的未来来说不是好消息。这对 Canopy Growth、Aurora Cannabis 或 Hexo 来说也不是好消息。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.fool.com/investing/2021/04/12/why-canopy-growth-aurora-cannabis-and-hexo-stocks/\">Motley Fool</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ACB":"奥罗拉大麻公司","CGC":"Canopy Growth Corporation","APHA":"Aphria Inc."},"source_url":"https://www.fool.com/investing/2021/04/12/why-canopy-growth-aurora-cannabis-and-hexo-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151812879","content_text":"Blame Aphria.\nWhat happened\nIt's Monday, and marijuana stocks are vaporizing.Canopy Growth (NASDAQ:CGC) stock is down a depressing 4.7%, and cannabis rivals Aurora Cannabis (NYSE:ACB) and Hexo (NYSE:HEXO) have both tumbled about 9% each.\nAnd if you want to know why, ask Aphria (NASDAQ:APHA).\nIMAGE SOURCE: GETTY IMAGES.\nSo what\nYes, unfair as it may feel, the stock to blame for Canopy's, Aurora's, and Hexo's declines today is none of the above, but rather their cannabis-growing rival Aphria, which reported itsfiscal Q3 2021earnings results this morning.\nSuffice it to say that the news was not good.\nSales at the Canadian cannabis company grew a respectable 6% to CA$153.6 million in Q3 2021, but that was well below the CA$166.2 million that analysts had predicted. Worse, Aphria reported a CA$1.14-per-share loss for the quarter, versus the tiny profit (calculated according to generally accepted accounting principles or GAAP) reported a year ago. In terms of U.S. dollars, Aphria lost $0.91 per share.\nNow what\nAphria blamed \"the duration and impact of lockdowns across many of the regions we operate in, particularly in Canada\" for its disappointing results, but insisted that it \"remains well-positioned with our leading brands and market share to experience a robust increase in our top-line as the market improves\" and said it is still \"excited about the strategic opportunities for incremental growth,\" particularly in the U.S. market.\nRegardless, the fact that Aphria's gross profits on its sales declined by nearly half in the quarter suggests that demand for the product isn't necessarily Aphria's (or Canopy's or Aurora's or Hexo's) biggest problem going forward. Shrinking profit on growing sales speaks to declining pricing power in the industry as oversupply continues to weigh on profitability for medical marijuana and recreational marijuana alike.\nThat's not good news for Aphria's future.It's not good news for Canopy Growth, Aurora Cannabis, or Hexo, either.","news_type":1,"symbols_score_info":{"APHA":0.9,"ACB":0.9,"HEXO":0.9,"CGC":0.9}},"isVote":1,"tweetType":1,"viewCount":596,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/345358733"}
精彩评论